Dexxos Participações Inkomsten in het verleden
Verleden criteriumcontroles 5/6
Dexxos Participações has been growing earnings at an average annual rate of 22.4%, while the Chemicals industry saw earnings growing at 12.9% annually. Revenues have been growing at an average rate of 18.4% per year. Dexxos Participações's return on equity is 20.5%, and it has net margins of 9.9%.
Belangrijke informatie
22.4%
Groei van de winst
22.3%
Groei van de winst per aandeel
| Chemicals Groei van de industrie | 20.4% |
| Inkomstengroei | 18.4% |
| Rendement op eigen vermogen | 20.5% |
| Nettomarge | 9.9% |
| Laatste winstupdate | 30 Jun 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Opbrengsten en kosten
Hoe Dexxos Participações geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 24 | 1,660 | 165 | 183 | 0 |
| 31 Mar 24 | 1,664 | 176 | 169 | 0 |
| 31 Dec 23 | 1,745 | 181 | 167 | 0 |
| 30 Sep 23 | 1,801 | 160 | 166 | 0 |
| 30 Jun 23 | 1,840 | 148 | 169 | 0 |
| 31 Mar 23 | 1,953 | 137 | 184 | 0 |
| 31 Dec 22 | 2,098 | 150 | 185 | 0 |
| 30 Sep 22 | 2,178 | 134 | 185 | 0 |
| 30 Jun 22 | 2,182 | 173 | 178 | 0 |
| 31 Mar 22 | 2,043 | 210 | 163 | 0 |
| 31 Dec 21 | 1,774 | 192 | 160 | 0 |
| 30 Sep 21 | 1,494 | 197 | 152 | 0 |
| 30 Jun 21 | 1,328 | 151 | 147 | 0 |
| 31 Mar 21 | 1,109 | 148 | 149 | 0 |
| 31 Dec 20 | 995 | 119 | 139 | 0 |
| 30 Sep 20 | 915 | 98 | 134 | 0 |
| 30 Jun 20 | 842 | 88 | 129 | 0 |
| 31 Mar 20 | 848 | 28 | 123 | 0 |
| 31 Dec 19 | 798 | 25 | 117 | 0 |
| 30 Sep 19 | 794 | 29 | 115 | 0 |
| 30 Jun 19 | 769 | 23 | 113 | 0 |
| 31 Mar 19 | 728 | 8 | 106 | 0 |
| 31 Dec 18 | 735 | 7 | 105 | 0 |
| 30 Sep 18 | 679 | 88 | 98 | 0 |
| 30 Jun 18 | 613 | 89 | 89 | 0 |
| 31 Mar 18 | 561 | 91 | 80 | 0 |
| 31 Dec 17 | 484 | 81 | 70 | 0 |
| 30 Sep 17 | 445 | 61 | 66 | 0 |
| 30 Jun 17 | 433 | 41 | 65 | 0 |
| 31 Mar 17 | 438 | 47 | 64 | 0 |
| 31 Dec 16 | 438 | 53 | 64 | 0 |
| 30 Sep 16 | 437 | -25 | 59 | 0 |
| 30 Jun 16 | 428 | -28 | 58 | 0 |
| 31 Mar 16 | 411 | -38 | 57 | 0 |
| 31 Dec 15 | 398 | -41 | 56 | 0 |
| 30 Sep 15 | 390 | -23 | 57 | 0 |
| 30 Jun 15 | 376 | -15 | 59 | 0 |
| 31 Mar 15 | 366 | -20 | 61 | 0 |
| 31 Dec 14 | 367 | -20 | 63 | 0 |
| 30 Sep 14 | 362 | 71 | 63 | 0 |
| 30 Jun 14 | 365 | 55 | 63 | 0 |
| 31 Mar 14 | 355 | 52 | 64 | 0 |
| 31 Dec 13 | 349 | 32 | 67 | 0 |
Kwaliteitswinsten: DEXP4 has high quality earnings.
Groeiende winstmarge: DEXP4's current net profit margins (9.9%) are higher than last year (8.1%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: DEXP4's earnings have grown significantly by 22.4% per year over the past 5 years.
Versnelling van de groei: DEXP4's earnings growth over the past year (11.3%) is below its 5-year average (22.4% per year).
Winst versus industrie: DEXP4 earnings growth over the past year (11.3%) exceeded the Chemicals industry -6.6%.
Rendement op eigen vermogen
Hoge ROE: DEXP4's Return on Equity (20.5%) is considered high.